Displaying 181 - 200 of 1557
Public Statement
Oral Remarks of Christine S. Wilson at Open Commission Meeting on June 16, 2022
Date
Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P221201
FTC Acts to Protect Pet Owners from Private Equity Firm’s Anticompetitive Acquisition of Veterinary Services Clinics
Date
The Federal Trade Commission today took action to protect competition in markets for specialty and emergency veterinary services by requiring the owner of a chain of veterinary clinics, JAB Consumer...
FTC and Justice Department to Hold Two-Day Virtual Public Workshop Starting Tomorrow that Re-examines Antitrust Enforcement in the Pharmaceutical Industry
Date
The Federal Trade Commission and the U.S. Department of Justice (DOJ) will host a two-day workshop starting tomorrow, that explores new approaches to enforcing the antitrust laws in the pharmaceutical...
Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers
Date
By
Lina M. Khan, Former Chair and Commissioner
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding 6(b) Study of Pharmacy Benefit Managers
Date
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
P221200
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
Date
The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information...
Statement of Commissioner Rebecca Kelly Slaughter Regarding 6(b) Study of Pharmacy Benefit Managers
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P221200
FTC Sues to Block Merger Between Utah Healthcare Rivals HCA Healthcare and Steward Health Care System
Date
The Federal Trade Commission has authorized an administrative complaint and a lawsuit in federal court to block the proposed merger between Utah healthcare competitors HCA Healthcare and Steward...
FTC Sues to Block Merger Between New Jersey Healthcare Rivals RWJBarnabas Health and Saint Peter’s Healthcare System
Date
The Federal Trade Commission authorized an administrative complaint and a suit in federal court to block the acquisition of Saint Peter’s Healthcare System by RWJBarnabas Health, or RWJ, which is one...
FTC and Justice Department to Hold Two-Day Virtual Public Workshop Examining Antitrust Enforcement in the Pharmaceutical Industry
Date
The Federal Trade Commission and the U.S. Department of Justice (DOJ) will host a two-day workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. The...
Federal Register Notice
Medtronic/Intersect ENT; Analysis of Agreement Containing Consent Orders To Aid Public Comment
Date
FTC Acts to Protect Patients Who Rely on Medical Instruments Used in Sinus Procedures
Date
The Federal Trade Commission took action today to protect patients who rely on medical instruments used in sinus procedures. The FTC’s order requires Medtronic, Inc. to divest a subsidiary of...
Federal Register Notice
Hikma Pharmaceuticals PLC/Custopharm, Inc.; Analysis of Agreement Containing Consent Orders To Aid Public Comment
Date
Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug
Date
The Federal Trade Commission today required – as a condition of Hikma Pharmaceuticals PLC’s $375 million acquisition of Custopharm, Inc. – that Custopharm’s parent company retain and transfer...
Statement of Federal Trade Commission Bureau of Competition Deputy Director John M. Newman on Federal Appeals Court Ruling Affirming Preliminary Injunction to Halt Merger of New Jersey Hospital Networks
Date
Federal Trade Commission Bureau of Competition Deputy Director John M. Newman issued this statement regarding the U.S. Court of Appeals for the Third Circuit decision affirming the district court’s...
Statement Regarding Termination of Attempted Merger of Rhode Island’s Two Largest Healthcare Providers
Date
In response to the announcement that Lifespan Corp. (“Lifespan”) and Care New England Health System (“Care New England”) have terminated their proposed merger, FTC Bureau of Competition Director Holly...
Lifespan/CNE, In the Matter of
The Federal Trade Commission authorized an administrative complaint, and a suit in federal court blocking the proposed merger of Rhode Island’s two largest healthcare providers. The agency alleged the deal would lead to higher prices and lower quality care. The FTC, jointly with the Rhode Island Office of the Attorney General, filed a complaint in federal district court seeking a temporary restraining order and preliminary injunction to stop the deal and to maintain the status quo pending an administrative trial on the merits of the case. On March 2, 2022, the Commission issued a statement regarding the parties’ decision to abandon the transaction.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
211 0031
Docket Number
9406
Case Status
Pending
Displaying 181 - 200 of 1557